Dysphagia after ischemic and hemorrhagic stroke: A propensity-matched 20-year analysis of the national inpatient sample.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 27 03 2023
revised: 23 07 2023
accepted: 02 08 2023
medline: 4 9 2023
pubmed: 7 8 2023
entrez: 6 8 2023
Statut: ppublish

Résumé

Dysphagia is a common symptom of acute ischemic stroke (AIS) and intracerebral hemorrhage (ICH), but little is known surrounding national trends of this post-stroke condition. Hence, this study aimed to identify the risk factors for dysphagia following AIS and ICH and evaluate in-hospital outcomes in these patients. The 2000-2019 Nationwide Inpatient Sample was queried for patients admitted with AIS (ICD9 433, 43401, 43411, 43491, ICD-10 I63) and ICH (ICD9 431, 432.9, ICD-10 I61, I62.9). Univariate analysis with t-tests or chi-square performed as appropriate. A 1:1 nearest neighbor propensity score matched cohort was generated. Variables with standardized mean differences >0.1 were used in multivariable regression to generate adjusted odds ratios (AOR)/β-coefficients for the presence of dysphagia on outcomes. Of 10,415,286 patients with AIS, 956,662 (9.2%) had in-hospital dysphagia. Total of 2,000,868 patients with ICH were identified; 203,511 (10.2%) had in-hospital dysphagia. Patients with dysphagia after AIS were less likely to experience in-hospital mortality (OR 0.61;95%CI: 0.60-0.63) or be discharged home (AOR 0.51;95%CI: 0.51-0.52), had increased length of stay (Beta-coefficient = 0.43 days; 95%CI: 0.36-0.50), and had increased hospital charges ($14411.96;95%CI: 13565.68-15257.44) (all p < 0.001). Patients with dysphagia after ICH were less likely to experience in-hospital mortality (AOR 0.39;95%CI: 0.37-0.4), less likely to be discharged home (AOR 0.59,95%CI:0.57-0.61), have longer hospital stay (Beta-coefficient = 1.99 days;95%CI: 1.78-2.21), and increased hospital charges ($28251.93; 95%CI: $25594.57-30909.28)(all p < 0.001). This is the first study to report on national trends in patients with dysphagia after AIS and ICH. These patients had longer hospital LOS, worse functional outcomes at discharge, and higher hospital costs.

Identifiants

pubmed: 37544059
pii: S1052-3057(23)00318-X
doi: 10.1016/j.jstrokecerebrovasdis.2023.107295
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107295

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Vikram Vasan (V)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA. Electronic address: vikram.vasan@icahn.mssm.edu.

Trevor A Hardigan (TA)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Muhammad Ali (M)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Margaret Downes (M)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Alex Devarajan (A)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Christina P Rossitto (CP)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Braxton R Schuldt (BR)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Ian C Odland (IC)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Christopher P Kellner (CP)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Johanna T Fifi (JT)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

J Mocco (J)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Shahram Majidi (S)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH